SCHEMBL2879340

SCHEMBL2879340

CC(C)(C)CC(c1cccc(O)c1)C(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 2/20 0.47
ADRA1A P35348 2/20 0.47
MIF P14174 1/20 0.47
HTR2A P28223 1/20 0.47
HTR2B P41595 1/20 0.47
HIF1A Q16665 4/20 0.45
ADRB2 P07550 1/20 0.45
HTR1A P08908 1/20 0.45
ADRA2A P08913 1/20 0.45
ADRB3 P13945 1/20 0.45
TSHR P16473 1/20 0.45
ADRA2B P18089 1/20 0.45
ADRA2C P18825 1/20 0.45
NFKB1 P19838 1/20 0.45
DRD1 P21728 1/20 0.45
HTR7 P34969 1/20 0.45
ADRA1B P35368 1/20 0.45
DRD3 P35462 1/20 0.45
RAB9A P51151 1/20 0.45
SLC6A3 Q01959 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14469724 0.81 ADRB1 (0.50) ADRB1ADRA1AMIFHTR2AHTR2B
SCHEMBL22920987 0.80 HIF1A (0.59) ADRB1ADRA1AMIFHTR2AHTR2B
SCHEMBL12018250 0.79 HSD17B10 (0.56) HIF1ATSHRSLC6A3CYP3A4HSD17B10
SCHEMBL18671644 0.79 ENPP2 (0.37) TSHRSLC6A3CYP3A4
SCHEMBL11162583 0.79 HIF1A (0.45) ADRB1ADRA1AMIFHTR2AHTR2B
SCHEMBL14725902 0.79 IDO1 (0.38) SLC6A3ALDH1A1CYP3A4
SCHEMBL25547849 0.78 ENPP2 (0.40) KDM4EALDH1A1CA2CA5ACA14
SCHEMBL29185565 0.78 HIF1A (0.47) ADRB1ADRA1AMIFHTR2AHTR2B
SCHEMBL24372163 0.77 OPRM1 (0.45) ADRB1ADRA1AMIFHTR2AHTR2B
SCHEMBL784711 0.77 ESR1 (0.44) ADRA1AHIF1AHTR1ATSHRDRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023162836-A1 ACTIVE-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, ACTIVE-RAY-SENSITIVE OR RADIATION-SENSITIVE FILM, PATTERN FORMATION METHOD, METHOD FOR MANUFACTURING ELECTRONIC DEVICE, AND COMPOUND 富士フイルム株式会社 2023-08-31 WO disclosed
US-20120237876-A1 RADIATION-SENSITIVE RESIN COMPOSITION, MONOMER, POLYMER, AND PRODUCTION METHOD OF RADIATION-SENSITIVE RESIN COMPOSITION JSR CORPORATION (JP) 2012-09-20 US disclosed
US-20120003583-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, AND RESIST FILM AND PATTERN FORMING METHOD USING THE COMPOSITION FUJIFILM CORPORATION (JP) 2012-01-05 US disclosed
US-7998655-B2 Method of forming patterns FUJIFILM CORPORATION (JP) 2011-08-16 US disclosed
US-7510822-B2 Stimulation sensitive composition and compound FUJIFILM CORPORATION (JP) 2009-03-31 US disclosed
US-20090042147-A1 METHOD OF FORMING PATTERNS FUJIFILM CORPORATION (JP) 2009-02-12 US disclosed
US-7449573-B2 Photosensitive composition, compound for use in the photosensitive composition, and method of pattern formation with the photosensitive composition FUJIFILM CORPORATION (JP) 2008-11-11 US disclosed
EP-1925979-A1 Positive photosensitive composition, polymer compound used for the positive photosensitive composition, production method of the polymer compound, and pattern forming method using the positive photosensitive composition FUJIFILM Corporation (JP) 2008-05-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120237876-A1 RADIATION-SENSITIVE RESIN COMPOSITION, MONOMER, POLYMER, AND PRODUCTION METHOD OF RADIATION-SENSITIVE RESIN COMPOSITION RAD51, RAD54L, MRE11 ADRB1 3217/4885ADRA1A 2684/4885MIF 3860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.